Technical Analysis for CANF - Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Grade Last Price % Change Price Change
D 2.04 -5.56% -0.12
CANF closed down 5.56 percent on Friday, February 26, 2021, on 43 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical CANF trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
200 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -5.56%
Calm After Storm Range Contraction -5.56%
Wide Bands Range Expansion -5.56%
Crossed Above 20 DMA Bullish -13.56%
Pocket Pivot Bullish Swing Setup -13.56%
Calm After Storm Range Contraction -13.56%
Older End-of-Day Signals for CANF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases. The company principally develops CF101 that is in Phase III study for the treatment of psoriasis; and has completed Phase II study for the treatment of rheumatoid arthritis and glaucoma, as well as completed Phase III study for the treatment of dry eye and Phase I study for the treatment of uveitis. It also develops CF102, which is in Phase II study for the treatment of hepatocellular carcinoma; and CF602 that has completed pre-clinical trial for the treatment of inflammatory diseases. The company was founded in 2000 and is based in Petach Tikva, Israel.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Immunology Treatment Of Cancer Inflammatory Disease Inflammatory Diseases Rheumatoid Arthritis Carcinoma Psoriasis Glaucoma Arthritis Hepatocellular Carcinoma Immunosuppressants Petach Uveitis Biotie Therapies Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases Treatment Of Psoriasis Immune Inflammatory Diseases

Is CANF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.98
52 Week Low 1.15
Average Volume 1,125,434
200-Day Moving Average 1.99
50-Day Moving Average 2.06
20-Day Moving Average 2.31
10-Day Moving Average 2.39
Average True Range 0.25
ADX 47.3
+DI 30.56
-DI 20.89
Chandelier Exit (Long, 3 ATRs ) 2.23
Chandelier Exit (Short, 3 ATRs ) 2.65
Upper Bollinger Band 2.76
Lower Bollinger Band 1.85
Percent B (%b) 0.21
BandWidth 39.46
MACD Line 0.06
MACD Signal Line 0.11
MACD Histogram -0.0537
Fundamentals Value
Market Cap 31.44 Million
Num Shares 15.4 Million
EPS -5.01
Price-to-Earnings (P/E) Ratio -0.41
Price-to-Sales 21.45
Price-to-Book 3.07
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.35
Resistance 3 (R3) 2.35 2.25 2.30
Resistance 2 (R2) 2.25 2.18 2.25 2.28
Resistance 1 (R1) 2.15 2.13 2.10 2.14 2.26
Pivot Point 2.05 2.05 2.02 2.05 2.05
Support 1 (S1) 1.94 1.97 1.89 1.94 1.82
Support 2 (S2) 1.84 1.92 1.84 1.80
Support 3 (S3) 1.74 1.84 1.78
Support 4 (S4) 1.73